Pharmaceutical and Device Pharmaceutical Reps Seen By Fewer Physicians Thomas Sullivan May 10, 2010 0 At a time when the use of drugs and medicine are increasingly being used to beneficially treat Americans in our health care…
Medical Societies CMSS Code for Interactions with Companies – Too Strict for Some, Not… Thomas Sullivan May 7, 2010 0 Last month, the Council of Medical Specialty Societies (CMSS), which represents 32 leading medical professional societies, with…
Research The Importance of Clinical Trials Thomas Sullivan May 7, 2010 0 A recent supplement in the Wall Street Journal discussed the importance of clinical trials, and provided an introduction to the…
Healthcare Reform Treating Elderly Patients: Geriatric Graduate and Continuing Medical… Thomas Sullivan May 6, 2010 0 With all the advances in health care and medicine over the past few decades, it is no wonder that Americans are living longer,…
State Policy State Policy: Vermont Senate Rejects Public Reporting of Pharmaceutical… Thomas Sullivan May 6, 2010 0 Looking to wrap up their legislative session by this weekend, the Vermont Senate easily passed a major health care reform bill,…
Physician Payment Disclosure Physician Payment Sunshine: Local Papers Get in The Act Thomas Sullivan May 5, 2010 0 Taking advantage of the new transparency and disclosure guidelines of several companies (Eli Lilly, Pfizer, GlaxoSmithKline,…
Congress House Appropriations Agriculture Subcommittee Hearing on Drug Safety Thomas Sullivan May 4, 2010 0 In response to the controversy created by diabetes drug Avandia (GlaxoSmithKline), the House Appropriations Subcommittee on…
State Policy Connecticut Considers Ban on FDA Regulated Industry Talks in Restaurants Thomas Sullivan May 3, 2010 0 According to a local news paper under the new health care reform law Connecticut will be facing a serious shortage of physicians…
Medical Legal Ortho-McNeil Settlement and Corporate Integrity Agreement Thomas Sullivan May 3, 2010 1 Last week was not the only settlement agreement (AstraZeneca) signed between a pharmaceutical company and the Office of…